Management of Patients With Graves’ Orbitopathy: Initial Assessment, Management Outside Specialised Centres and Referral Pathways | oneGRAVESvoice
Global Search
Global Search

Trusted Resources: Evidence & Education

Scientific literature and patient education texts

Back to Evidence & Education / Guides & Guidelines

Management of Patients With Graves’ Orbitopathy: Initial Assessment, Management Outside Specialised Centres and Referral Pathways

key information

source: Clinical Medicine: Journal of the Royal College of Physicians of London

year: 2015

authors: Perros P, Dayan CM, Dickinson AJ, Ezra D, Estcourt S, Foley P, Hickey J, Lazarus JH, MacEwen CJ, McLaren J, Rose GE, Uddin J, Vaidya B

summary/abstract:

Graves’ orbitopathy (GO) is uncommon, but responsible for considerable morbidity. A coordinated approach between healthcare professionals is required in order to meet the needs of patients. Early diagnosis can be achieved by a simple clinical assessment. Low-cost effective interventions can be initiated by generalists, which may improve outcomes. Moderate-to-severe GO should be referred to specialised centres. Recommendations for clinical diagnosis, initial management and referral pathways are highlighted.

organization: Newcastle upon Tyne, UK; Cardiff University, UK; Moorfields Eye Hospital, UK; Royal Devon and Exeter Hospital, UK; British Thyroid Foundation, UK; Ninewells Hospital, UK

DOI: 10.7861/clinmedicine.15-2-173

read more full text

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Powered by

Brought to you by

Supported through an independent
educational grant by

© 2022 rareLife solutions Inc.